Report cover image

IDWeek 2025: Pre-Conference Coverage

Publisher GlobalData
Published Oct 16, 2025
SKU # GBDT20602001

Description

IDWeek 2025: Pre-Conference Coverage

Summary

IDWeek is the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society and the Society of Infectious Diseases Pharmacists.

In advance of the confernece, GlobalData highlighted highly anticipated and noteworthy abstracts in this Pre-Conference Coverage report.

Scope

Indications, companies, and therapies discussed in the report are as follows -
  • Respiratory syncytial virus (RSV)
Moderna - mRNA-1345 (mRESVIA)

Enanta Pharmaceuticals - EDP-323
  • COVID-19
Moderna - mRNA-1273.815 (Spikevax XBB.1.5)

Invivyd - Pemivibart (Pemgarda)
  • Complicated urinary tract infections (cUTIs)/acute pyelonephritis
GSK and Spero Therapeutics - Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr)
  • HIV
ST Pharm - Pirmitegravir (STP0404)
  • Nontuberculous mycobacteria (NTM)
Paratek Pharmaceuticals - Omadacycline (Nuzyra)
  • Epstein Barr virus (EBV)
National Institute of Allergy and Infectious Diseases - EBV gp350 Ferritin Nanoparticle Vaccine Candidate adjuvanted with Matrix-M
  • Complicated Staphylococcus aureus bacteremia (SAB)
Armata Pharmaceuticals - AP-SA02
  • Fungal Infections
Elion Therapeutics - EL219

Reasons to Buy
  • This powerpoint-based deliverable highlights noteworthy conference abstracts, and the potential implications for your strategy, covering disease areas such as HIV, COVID-19, RSV, NTM, UTIs, and more.

Table of Contents

01. Executive Summary
02. Introduction
03. Capacity and Generation
04. Deal Analysis and New Investments
05. Market Forces Analysis
06. Project Status Analysis
07. Transmission and Distribution
08. Policy
09. Major Generating Companies
10. Appendix

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us